| NCT ID | NCT06407102 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Tours |
| Condition | Nasal Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-12-06 |
| Primary Completion | 2027-05-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-12-06 with a primary completion date of 2027-05-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Treatment and prevention of respiratory infections are of great interest in many medical areas. Create a physical device covered by primary human nasal cells could be very usefull in order to analyse delivery and efficiency of drugs. In this context the aim of this project is to create a collection of primary cells from the human nasal epithelium. This collection will be realised during programmed surgery, thanks to a specific device dedicated to collect nasal cells. Then the cells will be sent to the lab in order to grow at the air-liquid interface, which is an excellent 'ex vivo' model for their study.
Eligibility Criteria
Inclusion Criteria: * Adult patients (age \> 18 years) whose native language is French, or who understands French. * Affiliation with a French social security system (CMU accepted). * Informed consent, written and signed by the participant. * Planned rhinological surgery (meatotomy, septoplasty or turbinoplasty for example, but other surgeries as well) Exclusion Criteria: * Patients under court protection, guardianship or curatorship. * Pregnant or breast-feeding women (positive pregnancy test for women of childbearing age). * Patients presenting a major alteration of the mucosa or a malignant rhinosinus pathology.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06407102 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Nasal Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06407102 currently recruiting?
Yes, NCT06407102 is actively recruiting participants. Contact the research team at c.aussedat@chu-tours.fr for enrollment information.
Where is the NCT06407102 trial being conducted?
This trial is being conducted at Tours, France.
Who is sponsoring the NCT06407102 clinical trial?
NCT06407102 is sponsored by University Hospital, Tours. The trial plans to enroll 100 participants.